Factor XII: New life for an old protein

Thrombosis and Haemostasis

Volumn 104, Issue 5, 2010, Pages 915-918

  Schmaier, Alvin H ^a   LaRusch, Gretchen ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis and inhibitors; Contact phase; Factor XII; Integrins; Urokinase receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BLOOD CLOTTING FACTOR 12; CD31 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; HIGH MOLECULAR WEIGHT KININOGEN; MAMMALIAN TARGET OF RAPAMYCIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; UROKINASE;

ANGIOGENESIS; ANTIGEN EXPRESSION; AORTA; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; ENDOTHELIUM CELL; FIBRIN CLOT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN BIOPSY; THROMBOSIS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FACTOR VII; FACTOR XIIA; HEMOSTASIS; HISTORY, 20TH CENTURY; HUMANS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION;

EID: 78149487691     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-03-0171     Document Type: Conference Paper

References (33)

1. Schmaier AH, et al. High molecular weight kininogen: A secreted platelet protein. J Clin Invest 1983; 71: 1477-1489.
2. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of clot formation fraction of plasma. J Clin Invest 1955; 34: 602-613.
3. Ratnoff OD, et al. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest 1961; 40: 803-819.
4. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood coagulation. Science 1964; 145: 1310-1320.
5. Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its functions as a biochemical amplifier. Nature 1964; 202: 498-499.
6. Wilner GD, et al. Activation of Hageman factor by collagen. J Clin Invest 1968; 47: 2608-2615.
7. Ratnoff OD. Activation of Hageman factor by L-homocystine. Science 1968;162: 1007-1009.
8. Zacharski LR, Rosenstein R. Failure of collagen to activate factor XII. Thromb Res 1975; 7: 929-933.
9. Shariat-Madar Z, et alIdentifcation and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 2002; 277: 17962-17969. (Pubitemid 34967607)
10. Rojkjaer R, et al. Factor XII does not initiate prekallikrein activation on endothelial cells. Thromb Haemost 1998; 80: 74-81.
11. Renne T, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-281.
12. Kleinschnitz C, et al. Targeting coagulation factor XII provides protection from pathologic thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 2006; 203: 513-518.
13. Kannemeier C, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007; 104: 6388-6393.
14. Smith SA, et al. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903-908.
15. Maas C, et al. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008; 118: 3208-3218.
16. van der Meijden PEJ, et al. Dual role of collagen in factor XII-dependent thrombus formation. Blood 2009; 114: 881-890.
17. Stavrou E, Schmaier AH. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis and thrombosis. Thromb Res 2010; 125: 210-215.
18. Citarella F, et al. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII-an immunochemical and homology modeling approach. Thromb Haemost 2000; 84: 1057-1065.
19. Mahdi F, et al. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 2002; 99: 3585-3596.
20. Mahdi F, et al. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 2001; 97: 2342-2350.
21. Mahdi F, et al. Mapping the interaction between high molecular weight kininogen and the urokinase plasminogen activator receptor. J Biol Chem 2004; 279: 16621-16628.
22. Li Y, et al. Sequences within domain II of the urokinase receptor critical for differential ligand recognition. J Biol Chem 2003; 278: 29925-29932.
23. LaRusch GA, et al. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR ti initiate angiogenesis. Blood 2010; 115: 5111-5120.
24. Chien P, et al. Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor. J Clin Invest 1988; 82: 1554-1559.
25. Cool DE, MacGillivray RT. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. J Biol Chem 1987; 262: 13662-13672.
26. Schmeidler-Sapiro KT, et al. Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc Natl Acad Sci USA 1991; 88: 4382-4385.
27. Gordon EM, et al. Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci USA 1996; 93: 2174-2179.
28. Fernando AN, et al. Assembly, activation, and signaling by kinin-forming on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2005; 289: H251-H257.
29. Jacinto E, et al. SIN1/MIP1 maintains rector-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006; 127: 125-137.
30. Wei Y, et al. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol 2005; 168: 501-511.
31. Jo M, et al. Epidermal growth factor receptor-dependent and-independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem 2003; 278: 1642-1646.
32. Blacher S, et al. Improved quantification of angiogenesis in the aortic ring assay. Angiogenesis 2001; 4:133-142.
33. Schmaier AA, Schmaier AH. Thrombosis in flowing blood. Blood 2009; 114: 754-756.